Author:
Rodriguez-Gonzalez A,Cyrus K,Salcius M,Kim K,Crews C M,Deshaies R J,Sakamoto K M
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference51 articles.
1. Alarid ET, Preisler-Mashek MT, Solodin NM . (2003). Thyroid hormone is an inhibitor of estrogen-induced degradation of estrogen receptor-alpha protein: estrogen-dependent proteolysis is not essential for receptor transactivation function in the pituitary. Endocrinology 144: 3469–3476.
2. Bakin RE, Gioeli D, Sikes RA, Bissonette EA, Weber MJ . (2003). Constitutive activation of the Ras/mitogen-activated protein kinase signaling pathway promotes androgen hypersensitivity in LNCaP prostate cancer cells. Cancer Res 63: 1981–1989.
3. Bargagna-Mohan P, Baek SH, Lee H, Kim K, Mohan R . (2005). Use of PROTACS as molecular probes of angiogenesis. Bioorg Med Chem Lett 15: 2724–2727.
4. Blundell TL . (1996). Structure-based drug design. Nature 384: 23–26.
5. Borras M, Laios I, el Khissiin A, Seo HS, Lempereur F, Legros N et al. (1996). Estrogenic and antiestrogenic regulation of the half-life of covalently labeled estrogen receptor in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol 57: 203–213.
Cited by
166 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献